BE886319A - A-oxo-1h-thiazolo-(3,2-a)-pyrimidine-2-carboxamides, anti-allergiques et anti-ulcereux, medicament les contenant et composes intermediaires permettant de les obtenir - Google Patents

A-oxo-1h-thiazolo-(3,2-a)-pyrimidine-2-carboxamides, anti-allergiques et anti-ulcereux, medicament les contenant et composes intermediaires permettant de les obtenir

Info

Publication number
BE886319A
BE886319A BE0/202915A BE202915A BE886319A BE 886319 A BE886319 A BE 886319A BE 0/202915 A BE0/202915 A BE 0/202915A BE 202915 A BE202915 A BE 202915A BE 886319 A BE886319 A BE 886319A
Authority
BE
Belgium
Prior art keywords
thiazolo
carboxamides
ulcer
allergic
pyrimidine
Prior art date
Application number
BE0/202915A
Other languages
English (en)
French (fr)
Inventor
S Kadin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BE886319A publication Critical patent/BE886319A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
BE0/202915A 1979-11-23 1980-11-24 A-oxo-1h-thiazolo-(3,2-a)-pyrimidine-2-carboxamides, anti-allergiques et anti-ulcereux, medicament les contenant et composes intermediaires permettant de les obtenir BE886319A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9663179A 1979-11-23 1979-11-23

Publications (1)

Publication Number Publication Date
BE886319A true BE886319A (fr) 1981-05-25

Family

ID=22258306

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/202915A BE886319A (fr) 1979-11-23 1980-11-24 A-oxo-1h-thiazolo-(3,2-a)-pyrimidine-2-carboxamides, anti-allergiques et anti-ulcereux, medicament les contenant et composes intermediaires permettant de les obtenir

Country Status (35)

Country Link
JP (1) JPS5687586A (ru)
KR (1) KR830004322A (ru)
AR (2) AR228859A1 (ru)
AT (1) AT380883B (ru)
AU (1) AU520995B2 (ru)
BE (1) BE886319A (ru)
CA (1) CA1143731A (ru)
CH (1) CH649299A5 (ru)
CS (1) CS241476B2 (ru)
DD (1) DD154608A5 (ru)
DE (2) DE3043979C2 (ru)
DK (1) DK151811C (ru)
EG (1) EG14929A (ru)
ES (1) ES8203363A1 (ru)
FI (1) FI67706C (ru)
FR (1) FR2470132A1 (ru)
GB (1) GB2063862B (ru)
GR (1) GR72132B (ru)
GT (1) GT198066458A (ru)
HU (1) HU179091B (ru)
IE (1) IE50404B1 (ru)
IL (1) IL61535A (ru)
IN (1) IN154926B (ru)
IT (1) IT1209373B (ru)
LU (1) LU82950A1 (ru)
NL (1) NL182565C (ru)
NO (1) NO803521L (ru)
NZ (1) NZ195596A (ru)
PH (1) PH16666A (ru)
PL (1) PL132354B1 (ru)
PT (1) PT72090B (ru)
SE (1) SE448732B (ru)
SU (1) SU1042620A3 (ru)
YU (1) YU41953B (ru)
ZA (1) ZA807293B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8300728D0 (en) * 1983-01-12 1983-02-16 Erba Farmitalia Substituted carboxy-thiazolo / 3 2 - a / pyrimidine derivatives
US4457932A (en) * 1983-07-22 1984-07-03 Bristol-Myers Company Anti-ulcer agents
GB8422916D0 (en) * 1984-09-11 1984-10-17 May & Baker Ltd Compositions of matter
JP2690742B2 (ja) * 1987-03-30 1997-12-17 第一製薬株式会社 複素環アミン誘導体
NZ228447A (en) * 1988-03-28 1990-08-28 Janssen Pharmaceutica Nv Cosmetic or pharmaceutical composition possessing serotonin antogonistic activity
TWI500623B (zh) * 2009-10-13 2015-09-21 Torrent Pharmaceuticals Ltd 新穎稠合噻唑及噁唑嘧啶酮

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1331059A (en) * 1971-04-19 1973-09-19 Lilly Industries Ltd Pyrimidotriazinone compounds
US4041163A (en) * 1976-03-29 1977-08-09 Pfizer Inc. N-(5-Tetrazolyl)-4-oxo-4H-pyrimido(2,1-b)benzothiazole-3-carboxamide antiallergy agents
DE2810863A1 (de) * 1978-03-13 1979-09-27 Boehringer Mannheim Gmbh 1-oxo-1h-pyrimido eckige klammer auf 6,1-b eckige klammer zu benzthiazol-derivate und verfahren zu ihrer herstellung
US4223031A (en) * 1978-05-05 1980-09-16 Mead Johnson & Company Azolopyrimidinones

Also Published As

Publication number Publication date
IL61535A0 (en) 1980-12-31
LU82950A1 (fr) 1981-06-04
AR231296A1 (es) 1984-10-31
FR2470132B1 (ru) 1983-07-29
DK151811C (da) 1988-06-06
FI67706C (fi) 1985-05-10
FI803628L (fi) 1981-05-24
HU179091B (en) 1982-08-28
SE8008189L (sv) 1981-05-24
PT72090A (en) 1980-12-01
CS782080A2 (en) 1985-06-13
YU41953B (en) 1988-02-29
DE3050491C2 (de) 1985-10-10
NZ195596A (en) 1984-05-31
PL132354B1 (en) 1985-02-28
AU520995B2 (en) 1982-03-11
PT72090B (en) 1981-09-29
CS241476B2 (en) 1986-03-13
FR2470132A1 (fr) 1981-05-29
YU295080A (en) 1983-06-30
IE50404B1 (en) 1986-04-16
IT8026176A0 (it) 1980-11-21
EG14929A (en) 1989-01-30
GB2063862A (en) 1981-06-10
NL8006362A (nl) 1981-06-16
GT198066458A (es) 1982-05-15
NL182565B (nl) 1987-11-02
JPS617432B2 (ru) 1986-03-06
FI67706B (fi) 1985-01-31
DK413180A (da) 1981-05-24
SU1042620A3 (ru) 1983-09-15
CH649299A5 (fr) 1985-05-15
ES497066A0 (es) 1982-04-01
CA1143731A (en) 1983-03-29
DE3043979C2 (de) 1986-08-21
GB2063862B (en) 1983-06-22
SE448732B (sv) 1987-03-16
IT1209373B (it) 1989-07-16
PL228008A1 (ru) 1981-12-11
IN154926B (ru) 1984-12-22
AR228859A1 (es) 1983-04-29
JPS5687586A (en) 1981-07-16
AU6459580A (en) 1981-05-28
GR72132B (ru) 1983-09-19
ATA570780A (de) 1985-12-15
PH16666A (en) 1983-12-13
IL61535A (en) 1984-06-29
DD154608A5 (de) 1982-04-07
AT380883B (de) 1986-07-25
ES8203363A1 (es) 1982-04-01
DK151811B (da) 1988-01-04
DE3043979A1 (de) 1981-09-03
NO803521L (no) 1981-05-25
IE802418L (en) 1981-05-23
ZA807293B (en) 1981-12-30
KR830004322A (ko) 1983-07-09
NL182565C (nl) 1988-04-05

Similar Documents

Publication Publication Date Title
MA19048A1 (fr) Imidazo [1,2-a] pyridine,procedes pour leur preparation et composition pharmaceutiques les contenant .
BE855405A (fr) Nouvelles 4-amino-4-arylcyclohexanones, leur procede de preparation et medicament les contenant
BE862107A (fr) Nouveaux derives de 1,4-dihydropyridine substitues en position 2, leur procede de preparation et medicament les contenant
FI892636A (fi) Anordning och foerfarande foer fotografering och raekning av partiklar i roerelse.
BE894175A (fr) Nouvelles imidazotetrazinones, leur preparation et les medicaments qui les contiennent.
NL184895C (nl) Pyrido(3,4-f)-indoolderivaten met cytostatische eigenschappen, werkwijze voor het bereiden daarvan alsmede farmaceutische preparaten die dergelijke verbindingen bevatten.
FR2341578A1 (fr) Nouveaux derives d'indolizine, leur procede de preparation ainsi que les compositions therapeutiques les contenant
PT76573B (fr) Procede de preparation de derives d'imidazo <1,2-a> pyridine et de compositions pharmaceutiques les contenant
BE865015A (fr) Pseudotrisaccharides, leur procede de preparation et medicament les contenant
BE862608A (fr) Nouvelles imidazo (1,2-a)quinoxalines substitu2es en position 4, leur procede de preparation et medicament les contenant
BE886319A (fr) A-oxo-1h-thiazolo-(3,2-a)-pyrimidine-2-carboxamides, anti-allergiques et anti-ulcereux, medicament les contenant et composes intermediaires permettant de les obtenir
BE884075A (fr) Nouveaux dipeptides, leur preparation et les medicaments qui les contiennent
BE884620A (fr) Nouveaux derives d'halovincamone, leur procede de preparation et medicaments les contenant
BE884076A (fr) Nouveaux tripeptides, leur preparation et les medicaments qui les contiennent
FR2496100B1 (fr) Derives de la pyrazoline, leur preparation et medicaments contenant ces substances
BE858781A (fr) Nouveaux derives 1,4-dihydropyridiques de sucres, leur procede de preparation et medicament les contenant
BE863618A (fr) Nouveaux derives semi-synthetiques de 4"-amino-oleandomycine, leur procede de preparation et medicament les contenant
LU81182A1 (fr) Nouveaux derives de l'isoquinoleine,leur preparation et les compositions pharmaceutiques qui les contiennent
FR2468598B1 (fr) Thiazolidones-4 substituees en 2, leur procede de preparation et les medicaments les contenant
BE883204A (fr) Derives de la pyrazolo (1,5-c) quinazoline, procede de preparation de ces derives et medicaments contenant ces derniers
BE860126A (fr) Derives de 4,6-di-o-(aminoglycosyl)-1,3-diamino-cyclitols leur procede de preparation et compositions pharmaceutiques les contenant
FR2508040B1 (fr) Derives de proline, leur procede de preparation et medicament les contenant
BE863851A (fr) 2,4-dichlorophenyl-imidazolyl-ethanones ou -ethanols, leur procede de preparation et medicament les contenant
BE882674A (fr) Derives d'aminoisoquinoleine, leur procede de preparation et medicaments les contenant
FR2551753B2 (fr) Benzotriazine-1,2,3-ones-4, procede de preparation et medicaments les contenant

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: PFIZER INC.

Effective date: 19891130